More NJ Job Cuts: Novo Nordisk, RWJBarnabas Health, Barclays

šŸ’¼ Novo Nordisk is eliminating another 215 jobs in New Jersey, for a total of more than 300 this year.

šŸ’Š The latest reductions follow more than 800 layoffs in late 2025 at the drugmaker, with U.S. headquarters in NJ.

šŸ„ RWJBarnabas Health and Barclays are also cutting New Jersey jobs this month.


Some grim news for its workers, as Novo Nordisk has confirmed a new round of 215 layoffs in New Jersey.

The Danish pharmaceutical company, which has its U.S. headquarters in Plainsboro, announced the latest cuts will take effect in mid-February 2027.

This followed 108 layoffs made public in September — and over a year after Novo Nordisk quietly axed over 800 jobs in New Jersey, as part of a global restructuring.

Novo Nordisk makes both popular GLP-1 medications, Ozempic and Wegovy, among other drugs…

Story continues

TRENDING NOW

LATEST LOCAL NEWS